We Deliver Patient Advocacy
Founder, Syncofy LLC · Precision medicine data science
I build KOL intelligence infrastructure for pharmaceutical commercial teams through Syncofy LLC. The core product — kolx.syncofy.ai — surfaces publication velocity, trial PI status, and recency signal to replace CRM-based lists that go stale on contact.
My background spans oncology data science, drug development, and pharma commercial analytics. The same systematic measurement approach that motivated the DubbelHelix TGS biomarker (2011) now runs against physician publication and trial data at scale.
NIL Predictor
Predict college athlete NIL value, deal count, tier, transfer portal probability, and draft prospects. Free — no sign-up.
Try free →J Yo — Writing
Personal essays and dispatches. Published on Substack, mirrored here.
Blog
Ideas and conjecture — on pharma data, AI, and knowledge work.
Gallery
Photos and images — personal and professional.
Patient Resources
Cancer advocacy, clinical trial links, and community resources — rooted in the DubbelHelix portal mission.
DubbelHelix
The origin story — cancer patient portal (2011) → CombImmune Inc. → Syncofy LLC. Stanford TGS biomarker lineage.
Food Safety Map
Interactive US choropleth of CDC-reported foodborne illness outbreaks by state (2020–2023). Click any state for pathogen and food vehicle details.
Marine Botany
Undergraduate term project on Laminariales (kelp) — taxonomy, morphology, habitat, life history, and commercial uses. UC Santa Cruz Biology.